A Study to Investigate LYL797 in Adults With Solid Tumors

NCT05274451 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
57
Enrollment
INDUSTRY
Sponsor class

Stopped Pipeline Reprioritization

Conditions

Interventions

Sponsor

Lyell Immunopharma, Inc.